L-dopa plasma levels and executive functions in Parkinson's disease

被引：0
|
作者：
Albani, G.
Cattaldo, S.
Mori, I.
Pignatti, R.
Pradotto, L.
Mauro, A.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [41] Disease progression and increased L-dopa efficacy with time in Parkinson's disease
    Holford, NHG
    Chan, PLS
    Lee, YY
    Nutt, JG
    [J]. MOVEMENT DISORDERS, 2002, 17 : S112 - S112
  • [42] Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients
    Bartosova, O.
    Bonnet, C.
    Ulmanova, O.
    Sima, M.
    Perlik, F.
    Ruzicka, E.
    Slanar, O.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (04) : 699 - 703
  • [43] L-dopa therapy for Parkinson's disease: Past, present, and future
    Nagatsu, Toshiharu
    Sawada, Makoto
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S3 - S8
  • [44] L-dopa related hyperhomocysteinemia and development of dementia in Parkinson's disease
    dell'Aquila, C.
    Zoccolella, S.
    Mascolo, L.
    Abruzzese, G.
    Antonini, A.
    Bonuccelli, U.
    Dlazio, G.
    Pacchetti, C.
    Lamberti, P.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S249 - S249
  • [45] Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa
    A. W. Michell
    Z. Xu
    D. Fritz
    S. J. G. Lewis
    T. Foltynie
    C. H. Williams-Gray
    T. W. Robbins
    R. H. S. Carpenter
    R. A. Barker
    [J]. Experimental Brain Research, 2006, 174 : 7 - 18
  • [46] Arguments favoring early treatment of Parkinson's disease with L-Dopa
    Broussolle, E
    [J]. REVUE NEUROLOGIQUE, 1999, 155 (01) : 27 - 33
  • [47] Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease
    Subhani, F. U. -H.
    Subhani, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S119
  • [48] Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease
    Nissen, T.
    Newman, E. J.
    Grosset, K. A.
    Daghem, M.
    Pal, G.
    Stewart, M.
    Odin, P.
    Macphee, G. J.
    Grosset, D. G.
    [J]. MOVEMENT DISORDERS, 2011, 26 : S259 - S259
  • [49] Impact of l-dopa on sleep and cognitive performance in Parkinson's disease
    Holinka, B
    Ruff, H
    Malak, J
    Calabrese, P
    Gehlen, W
    [J]. SLEEP, 2002, 25 : A256 - A256
  • [50] L-dopa impairs learning, but spares generalization, in Parkinson's disease
    Shohamy, D
    Myers, CE
    Geghman, KD
    Sage, J
    Gluck, MA
    [J]. NEUROPSYCHOLOGIA, 2006, 44 (05) : 774 - 784
12345